These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 4782100)

  • 21. [Rifampicin in the treatment of newly detected adolescent pulmonary tuberculosis patients].
    Ganiev KG; Esanbaev DE; Kirina SB
    Probl Tuberk; 1983 May; (5):42-6. PubMed ID: 6866983
    [No Abstract]   [Full Text] [Related]  

  • 22. Serum concentration and urinary elimination of ethambutol administered alone and in combination with rifampin in patients of pulmonary tuberculosis.
    Singhal KC; Rathi R; Kishore K; Varshney SC; Varshney DP
    J Indian Med Assoc; 1986 Dec; 84(12):376-8. PubMed ID: 3585015
    [No Abstract]   [Full Text] [Related]  

  • 23. [Current aspects in treatment of tuberculosis].
    Tala E
    Duodecim; 1976; 92(10):505-13. PubMed ID: 1084829
    [No Abstract]   [Full Text] [Related]  

  • 24. [Reduction of fresh forms of pulmonary tuberculosis by the classical treatment and by combined antibiotics including rifampicin (comparative study of a personal survey)].
    Weill G; Lévy A; Guignon JP; Lecoq H; Friess JM; Maman P
    Rev Tuberc Pneumol (Paris); 1969 Dec; 33(8):1119-25. PubMed ID: 4916253
    [No Abstract]   [Full Text] [Related]  

  • 25. [Modern tuberculosis therapy].
    Krohn J
    Tidsskr Nor Laegeforen; 1973 Dec; 93(35):2576-8. PubMed ID: 4772808
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of intractable pulmonary tuberculosis: place of capreomycin in therapeutic programs with rifampicin and ethambutol].
    Oury M; Tuchais E; Norval C; Carbonnelle B; Leroux MF; Corre C; Parvery F
    Rev Tuberc Pneumol (Paris); 1970 Jun; 34(4):519-30. PubMed ID: 5510321
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of chronic tuberculosis patients with ethambutol and protoionamide combined with rifampicin and capreomicin].
    Grassi C; Cornia G; Cirianni C; Garimoldi M; Ginesu F; Mandler F; Perna G; Pradella F
    G Ital Chemioter; 1968; 15(4):92-4. PubMed ID: 5744843
    [No Abstract]   [Full Text] [Related]  

  • 28. [Rifampicin combined with ethambutol and other antitubercular agents in the treatment of patients with chronic pulmonary tuberculosis. Early results. II. Analysis of causes of treatment interruption].
    Masztalerz J
    Pneumonol Pol; 1976 Feb; 44(2):153-61. PubMed ID: 940788
    [No Abstract]   [Full Text] [Related]  

  • 29. [3 cases of treatment of advanced tuberculosis with multiresistant bacilli by combined rifomycin-ethambutol].
    Hennebert A
    Acta Tuberc Pneumol Belg; 1969; 60(3):507-12. PubMed ID: 5371675
    [No Abstract]   [Full Text] [Related]  

  • 30. [Rifampicin; its value and its limitations in tuberculosis, chronic or of severe onset, with or without associated ethambutol].
    Tricoire J; Marécaux L
    Rev Tuberc Pneumol (Paris); 1969 Mar; 33(2):226-41. PubMed ID: 5385585
    [No Abstract]   [Full Text] [Related]  

  • 31. [Rifampicin and ethambutol in treating chronic destructive pulmonary tuberculosis].
    Roslik SM; Iakovleva LM; Zhitnaia VI; Grushevskiĭ ES; Poluianova RP
    Probl Tuberk; 1980 Jun; (6):30-3. PubMed ID: 7393907
    [No Abstract]   [Full Text] [Related]  

  • 32. Controlled study on rifampicin in first treatment of fresh cases of pulmonary tuberculosis.
    Kraan JK; Mulder RJ; van Dijk B
    Acta Tuberc Pneumol Belg; 1969; 60(3):557-62. PubMed ID: 4906104
    [No Abstract]   [Full Text] [Related]  

  • 33. [Initial provisional record of treatment of relapses of active pulmonary tuberculosis with combined rifomycin, ethambutol and thiocarlide].
    Favez G; Willa C
    Acta Tuberc Pneumol Belg; 1969; 60(3):496-500. PubMed ID: 5392721
    [No Abstract]   [Full Text] [Related]  

  • 34. [Changes in the bacteriologic findings in patients treated with rifomycin, alone or associated with other drugs].
    Delli Veneri F; Centrella G; Stefanelli R
    Arch Tisiol Mal Appar Respir; 1968 May; 23(5):387-98. PubMed ID: 4979475
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapeutic effect of rifampicin on re-treatment cases of pulmonary tuberculosis. The second study: a study on the combined therapy of rifampicin with ethambutol and pyrazinamide, especially on intermittent therapy].
    Kekkaku; 1972 Dec; 47(12):457-66. PubMed ID: 4652424
    [No Abstract]   [Full Text] [Related]  

  • 36. [Reactivation of pulmonary tuberculosis in patients treated with rifampicin and ethambutol].
    Kuznetsova ZA
    Probl Tuberk; 1985; (12):40-2. PubMed ID: 4095097
    [No Abstract]   [Full Text] [Related]  

  • 37. [Results of treatment of chronically infectious patients with rifampicin in various combinations and in various models].
    Górecki R; Stanek S
    Gruzlica; 1974 May; 42(5):411-6. PubMed ID: 4464229
    [No Abstract]   [Full Text] [Related]  

  • 38. Rifampicin in newly detected, untreated cases of pulmonary tuberculosis.
    Meissner G
    Acta Tuberc Pneumol Belg; 1969; 60(3):554-6. PubMed ID: 4906103
    [No Abstract]   [Full Text] [Related]  

  • 39. [Proceedings: Preliminary results of a 2-phase therapy with rifampicin, ethambutol and a third drug in chronic polyresistant tuberculoses].
    Neumeyer D; Anschel R; Eule H; Fichtner K; Ganguin HG; Pickroth G
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):135-8. PubMed ID: 4491710
    [No Abstract]   [Full Text] [Related]  

  • 40. [ rpceedomgs" Intermittent 2-phase regimen in therapy of chronic pulmonary tuberculosis].
    Zierski M
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):116-23. PubMed ID: 4491708
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.